Financial Instruments - Narrative (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Jan. 31, 2024 |
Jan. 31, 2023 |
Jan. 31, 2022 |
|
| Investments, All Other Investments [Abstract] | |||
| Securities in continuous unrealized loss position for greater than twelve months | $ 0 | $ 0 | |
| Allowance for credit loss | 0 | 0 | |
| Securities, writeoff | 0 | 0 | |
| Marketable debt securities | 764,000,000 | 450,000,000 | $ 38,000,000 |
| Direct investments in privately held companies | $ 162,000,000 | $ 177,000,000 | |
| X | ||||||||||
- Definition Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of writeoff of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. No definition available.
|